English
慶應義塾大学 
薬学部 
薬学科 

助教 
市川 大樹 
イチカワ ダイジュ 
ICHIKAWA Daiju 

研究業績(原著論文・解説)
研究論文(学術雑誌)  共著  NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome.  市川 大樹  J Exp Med.  2017/09/06  10.1084/jem.20170497 
研究論文(学術雑誌)  共著  A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest.  市川 大樹  Biochem Biophys Res Commun.  2017/09/01  10.1016/j.bbrc.2017.08.159 
研究論文(学術雑誌)  共著  Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma.  市川 大樹  2017/08/30  10.1016/j.bmcl.2017.08.054 
研究論文(学術雑誌)  共著  Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.  市川 大樹  J Exp Med  213/ 13, 3007-3024  2016/12/12 
研究論文(学術雑誌)  共著  Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies  市川 大樹  PLOS ONE  11/ 1  2016/01  1932-6203  10.1371/journal.pone.0146371 
詳細表示...

研究業績(口頭・ポスター発表)
ポスター発表  Komaroviquinone-Derivatives, Revealed Anti-Tumor Effect on High-Risk Multiple Myeloma Cells In Vitro as Well as In Vivo  ASH, 58th Annual Meeting & Exposition  2016/12/03 
口頭発表(一般)  Structural optimization and anti-tumor activities of komaroviquinone to high-risk myeloma  第78回日本血液学会学術集会  2016/10/13 
ポスター発表  ハイリスク多発性骨髄腫に対する新規komaroviquinone誘導体による克服薬の開発  第41回日本骨髄腫学会学術集会  2016/05/29 
ポスター発表  Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs  57th Annual Meeting and Exposition  2015/12/05 
ポスター発表  Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI.  30th Annual Meeting of The Society for Immunotherapy of Cancer(SITC)  2015/11/05 
詳細表示...